Related Experiment Video
Updated: May 20, 2026

04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Electroconvulsive Therapy for Severe Refractory Tardive Dystonia Without Active Depression: A Case Report
Tomohiro Asahi1, Yasushi Kawamata1, Norio Sugawara1
1Department of Psychiatry, Dokkyo Medical University, Tochigi, Shimotsuga, Japan.
Neuropsychopharmacology Reports
|May 19, 2026
Summary
Electroconvulsive therapy (ECT) can significantly improve severe tardive dystonia, a movement disorder caused by certain medications. While effective short-term, symptoms may return, necessitating ongoing treatment strategies.
Area of Science:
- Neurology
- Psychiatry
- Movement Disorders
Background:
- Tardive dystonia is a disabling condition resulting from dopamine receptor-blocking agents.
- Pharmacological treatments for tardive dystonia often yield limited results.
- Evidence for electroconvulsive therapy (ECT) in treating tardive dystonia is scarce.
Keywords:
abnormal involuntary movement scalebenzodiazepineselectroconvulsive therapymovement disorderstardive dystoniatardive syndromevalbenazineMore Related Videos
Related Concept Videos
Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

